Tarheel Investors, a KKR-controlled 10% holder, took $604 million in cash from Integer's $5.7 billion buyout
The November 17 Form 4 shows one firm on both sides of the take-private: KKR-managed funds paid $127 a share for the medical-device maker while a KKR-controlled 10% holder took cash instead of rolling into the deal. For KKR & Co. shareholders, it is the working end of the capital turn out of USI and into Strategic Holdings.
Richard Tangtwo-minute read
Integer Holdings left the New York Stock Exchange on November 17, 2026, bought by investment funds managed by KKR in a take-private valuing the medical-device contract manufacturer at about $5.7 billion 2. The completion release named the buyer, the price and the chief executive's enthusiasm. A Form 4 filed the same day named the seller nobody mentioned, and the two share a firm 2.
The release named no sellers; the Form 4 did
Tarheel Investors III L.P. sold every Integer share it held at the merger price of $127, taking home about $604 million and reporting nothing left over 1. The stake was 4.75 million shares, a position of just over 10% 17. A cash-settled swap covering 836,392 more shares settled at the same price, roughly $106 million on top, for about $710 million in all 1. Integer's announcement of the closing names no recipients of that money 2.
One firm on both sides of the trade
Tarheel's chain of control runs from its general partner through KKR−0.81% — KKR, down 0.81 percent today North America Fund XIV and KKR Group Partnership L.P. up to KKR & Co. Inc., the listed manager, and to founding partners Henry Kravis and George Roberts, every entity in it reporting the stake as a 10% owner 1. They took cash rather than rolling into the buyer group, and KKR registered the 10% position only in mid-October, after the merger agreement was signed on August 2 17. The flow is disclosed and ordinary; related-party cash is what Form 4 filing exists to show 17.
This is the USI money at work
Chief Financial Officer Rob Lewin framed the turn on November 12: selling insurance broker USI to Aon for $17 billion frees more than $3 billion of liquidity and over $2 billion of profit 46. Integer is one of three Strategic Holdings purchases meant to replace USI's operating earnings by 2030, a segment Lewin expects to grow from more than $350 million toward $1.1 billion 4.
The competing use is the buyback, more than $900 million repurchased this year near $92 a share 4. The same menu feeds Helix, KKR's AI-infrastructure arm, which raised $10 billion of founding equity plus another $1 billion from Samsung 4.
KKR's revenue has swung between $3.1 billion and $5.7 billion a quarter for two years
- Revenue
- Net income
Data
| Revenue | Net income | |
|---|---|---|
| Q2 '24 | $4.17B | $0.67B |
| Q3 '24 | $4.79B | $0.6B |
| Q4 '24 | $3.26B | $1.13B |
| Q1 '25 | $3.11B | -$0.19B |
| Q2 '25 | $5.09B | $0.51B |
| Q3 '25 | $5.53B | $0.9B |
| Q4 '25 | $5.74B | $1.15B |
| Q1 '26 | $4.32B | $0.41B |
| Q2 '26 | $5.73B | $0.7B |
| Q3 '26 | $4.56B | $1.16B |
Read the filings, not the releases
The swap was set to run to January 2029; the merger pulled settlement forward 1. The cash that moved last week is reported. The Strategic Holdings target for 2030 is a projection, and it is the part that has to work 4. The press release tells you who bought Integer; the Form 4 tells you who got paid 4.
Get Deals by email, free
The acquisitions, rounds and contracts that move AI money. In our daily email, every weekday.






Reader comments
0 comments